KakinamiL, AdamsMJ, BlockRCet al.Risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients. AIDS Res Hum Retroviruses, 2012; 28:1552–1556.
2.
ManickamP, RathodA, PanaichSet al.Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: Do novel lipid parameters offer an advantage?J Clin Lipidol, 2011; 5:82–90.
3.
DiongC, RaboudJ, LiMet al.HIV/hepatitis C virus and HIV/hepatitis B virus coinfections protect against antiretroviral-related hyperlipidaemia. HIV Med, 2011; 12:403–411.
4.
NaingC, MakJW, AhmedSIet al.Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis. World J Gastroenterol, 2012; 18:1642–1651.
5.
AbdoAA, LeeSS. Hepatitis C, insulin resistance and fatty liver: Bad things come in threes. Can J Gastroenterol, 2012; 26:323.
6.
LiC, FordES, MengYXet al.Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?Cardiovasc Diabetol, 2008; 7:4.
